Mafosfamide
Jump to navigation
Jump to search
<templatestyles src="Chembox/styles.css"/>
Template:Chembox image cellTemplate:Chembox image cellTemplate:Chembox AllOtherNamesTemplate:Chembox headerbarTemplate:Chembox IndexlistTemplate:Chembox JmolTemplate:Chembox ChEMBLTemplate:Chembox ECHATemplate:Chembox E numberTemplate:Chembox IUPHAR ligandTemplate:Chembox UNIITemplate:Chembox CompToxTemplate:Chembox headerbarTemplate:Chembox Datapage checkTemplate:Chembox Footer| Template:Longitem | Template:Unbulleted list |
| ChEBI | Template:Unbulleted list |
| ChemSpider | Template:Unbulleted list |
| DrugBank | Template:Unbulleted list |
| EC Number | Template:Unbulleted list |
| KEGG | Template:Unbulleted list |
| MeSH | Mafosfamide |
| Template:Longitem | Template:Unbulleted list |
| RTECS number | Template:Unbulleted list |
| Script error: No such module "collapsible list". | |
| Script error: No such module "collapsible list". | |
| Template:Longitem | C9H19Cl2N2O5PS2 |
| Molar mass | 401.269 g/mol |
Template:Chembox Footer/trackingScript error: No such module "TemplatePar".Template:Short description
Mafosfamide (INN) is an oxazaphosphorine (cyclophosphamide-like) alkylating agent under investigation as a chemotherapeutic. It is metabolized by cytochrome P450 into 4-hydroxycyclophosphamide, which is then converted into aldophosphamide, which, in turn yields the cytotoxic metabolites phosphoramide mustard and acrolein.[1]
Several Phase I trials have been completed.[2][3]
References
<templatestyles src="Reflist/styles.css" />
- ↑ Ludeman SM. The chemistry of the metabolites of cyclophosphamide. Curr Pharm Des. 1999 Aug;5(8):627-43. Template:Catalog lookup link
- ↑ Script error: No such module "citation/CS1". ClinicalTrials.gov Identifier NCT00062881.
- ↑ Script error: No such module "citation/CS1". ClinicalTrials.gov Identifier NCT00031928.
Script error: No such module "Check for unknown parameters".
Script error: No such module "Navbox".